Novel Science.
Expert Leadership.

Jasper Therapeutics’ management team is comprised of experienced biopharma industry veterans with extensive track records in drug development and commercialization. With this leadership, we are well positioned to achieve our vision of developing new therapies to treat both chronic and life-threatening mast and stem cell diseases.


Ronald Martell

Chief Executive Officer

Jeet Mahal

Chief Operating Officer

Edwin Tucker, M.D.

Chief Medical Officer

Herb Cross

Chief Financial Officer

Wendy Pang, M.D., Ph.D.

Senior Vice President, Research and Translational Medicine

Patricia Carlos

Senior Vice President, Regulatory Affairs & Quality

Luca Di Noto, Ph.D.

Senior Vice President, Technical Operations

David Ku, M.D.

Vice President, Corporate Development, Portfolio Strategy & Management

Annette Marcantonio

Vice President, Clinical Operations

Matt Ford

Vice President, Human Resources

Board Of Directors

Thomas Wiggans – Chair

Judith Shizuru, M.D., Ph.D.

Kurt von Emster

Svetlana Lucas, Ph.D.

Chris Nolet

Vishal Kapoor

Scott Brun, M.D.

Ronald Martell

Scientific Advisory Board

Jasper Therapeutics has established a premier, world-class Scientific Advisory Board of accomplished scientific leaders who are experts in immunology, inflammation, mast cells, stem cells, blood and bone marrow transplantation, and hematologic cancers.

Judith Shizuru, M.D., Ph.D.

Art Weiss, M.D., Ph.D.

Fred Appelbaum, M.D.

Jeffrey Ravetch, M.D., Ph.D.

Harry Malech, M.D.

Stephen J. Galli, M.D.

Dan Adelman, M.D.